Lysosomal Disorders

GeneTherapyLive’s Weekly Rewind – November 26, 2021

Review top news and interview highlights from the week ending November 26, 2021.

Developing Gene Therapies for Indications With Unmet Needs

The chief executive and scientific officers of Lysogene discussed Lysogene’s patient-focused therapy development.

Advantages of Developing Platform-Agnostic Gene Therapies

The chief executive officer of Rocket Pharmaceuticals, Gaurav Shah, MD, discussed the company’s ex-vivo and in-vivo gene therapy platforms.